SCHEMBL22484610

SCHEMBL22484610

CCCCCCCCCC1CC(C)OO1

nearest known ligand 0.54

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.54
▸ EPHX1 P07099 1/20 0.50
▸ CYP1A2 P05177 2/20 0.42
▸ EBP Q15125 1/20 0.37
▸ SIGMAR1 Q99720 1/20 0.37
▸ ALOX5 P09917 1/20 0.35
▸ PPARG P37231 2/20 0.35
▸ GRM2 Q14416 3/20 0.33
▸ SPHK2 Q9NRA0 2/20 0.33
▸ SPHK1 Q9NYA1 2/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22482940 0.83 ALDH1A1 (0.58) ALDH1A1EPHX1CYP1A2ALOX5PPARG
SCHEMBL22482952 0.83 ALDH1A1 (0.58) ALDH1A1EPHX1CYP1A2ALOX5PPARG
SCHEMBL22483050 0.78 ALDH1A1 (0.52) ALDH1A1EPHX1CYP1A2ALOX5PPARG
SCHEMBL22484374 0.78 ALDH1A1 (0.52) ALDH1A1EPHX1CYP1A2ALOX5PPARG
SCHEMBL22470028 0.78 ALDH1A1 (0.52) ALDH1A1EPHX1CYP1A2ALOX5PPARG
SCHEMBL22484690 0.78 ALDH1A1 (0.52) ALDH1A1EPHX1CYP1A2ALOX5PPARG
SCHEMBL17210446 0.76 EPHX1 (0.62) ALDH1A1EPHX1CYP1A2EBPSIGMAR1
Propylene Oxide SCHEMBL29006023 0.74 ALDH1A1 (0.86) ALDH1A1EPHX1CYP1A2EBPSIGMAR1
SCHEMBL22471646 0.73 ALDH1A1 (0.47) ALDH1A1EPHX1CYP1A2ALOX5PPARG
SCHEMBL22470039 0.73 ALDH1A1 (0.47) ALDH1A1EPHX1CYP1A2ALOX5PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020193649-A1 NEW THERAPEUTIC APPLICATION OF 1,2-DIOXOLANE-3,5-DISUBSTITUTED COMPOUNDS, AND METHOD FOR THE PRODUCTION THEREOF Universite Paris-Saclay (FR) 2020-10-01 — — WO disclosed
Send feedback